News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Hollis-Eden Pharmaceuticals Inc. Terminates CEO
March 24, 2009
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Hollis-Eden Pharmaceuticals' founder and Chief Executive Richard Hollis was fired "for cause" by his board last week, triggering a clause in his employment contract that strips him of millions of dollars in severance payments.
Twitter
LinkedIn
Facebook
Email
Print
People
MORE ON THIS TOPIC
Series B
City Therapeutics builds RNAi pipeline with $99.5M series B
June 8, 2026
·
2 min read
·
Tristan Manalac
Deals
J&J glows with $1B buyout of Firefly and its degrader platform tech
June 8, 2026
·
1 min read
·
Gabrielle Masson
Layoff Tracker
Fulcrum axes 85% of staff after walking away from lead asset
June 8, 2026
·
58 min read
·
BioSpace Editorial Staff
Mergers & acquisitions
Incyte’s stars align as new CEO strikes $2B Vega takeover for blood disorder asset
June 8, 2026
·
2 min read
·
Annalee Armstrong
